Melanie Odenkirk

Ms. Melanie Odenkirk

North Carolina State University, Raleigh, NC, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2020 in Molecular Omics
Verified
Journal Article
Closed access
PDF file
MOMelanie Odenkirk
Melanie Odenkirk
KSKelly G. Stratton
Kelly G. Stratton
MGMarina A Gritsenko
Marina A Gritsenko
LBLisa M. Bramer
Lisa M. Bramer
BWBobbie-Jo M. Webb-Robertson
Bobbie-Jo M. Webb-Robertson
Erin BakerErin Baker
Erin Baker
To fully enable the development of diagnostic tools and progressive pharmaceutical drugs, it is imperative to understand the molecular changes occurring before and during disease onset and progression. Systems biology assessments utilizing multi-omic analyses (e.g. the combination of proteomics, lipidomics, genomics, etc.) have shown enormous value in determining molecules prevalent in diseases and their associated mechanisms. Herein, we utilized multi-omic evaluations, multi-dimensional analysis methods, and new cheminformatics-based visualization tools to provide an in depth understanding of the molecular changes taking place in preeclampsia (PRE) and gestational diabetes mellitus (GDM) patients. Since PRE and GDM are two prevalent pregnancy complications that result in adverse health effects for both the mother and fetus during pregnancy and later in life, a better understanding of each is essential. The multi-omic evaluations performed here provide new insight into the end-stage molecular profiles of each disease, thereby supplying information potentially crucial for earlier diagnosis and treatments.

8 September 2022 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
SWShannah K. Witchey
Shannah K. Witchey
MDMichael G. Doyle
Michael G. Doyle
JFJacob D. Fredenburg
Jacob D. Fredenburg
GAGenevieve St. Armour
Genevieve St. Armour
BHBrian Horman
Brian Horman
HPHeather Patisaul
Heather Patisaul
Introduction: Flame retardants (FRs) are common bodily and environmental pollutants, creating concern about their potential toxicity. We and others have found that the commercial mixture FireMaster® 550 (FM 550) or its individual brominated (BFR) and organophosphate ester (OPFR) components are potential developmental neurotoxicants. Using Wistar rats, we previously reported that developmental exposure to FM 550 or its component classes produced sex- and compound-specific effects on adult socioemotional behaviors. The underlying mechanisms driving the behavioral phenotypes are unknown. Methods: To further mechanistic understanding, here we conducted transcriptomics in parallel with a novel lipidomics approach using cortical tissues from newborn siblings of the rats in the published behavioral study. Inclusion of lipid composition is significant because it is rarely examined in developmental neurotoxicity studies. Pups were gestationally exposed via oral dosing to the dam to FM 550 or the BFR or OPFR components at environmentally relevant doses. Results: The neonatal cortex was highly sexually dimorphic in lipid and transcriptome composition, and males were more significantly impacted by FR exposure. Multiple adverse modes of action for the BFRs and OPFRs on neurodevelopment were identified, with the OPFRs being more disruptive than the BFRs via multiple mechanisms including dysregulation of mitochondrial function and disruption of cholinergic and glutamatergic systems. Disrupted mitochondrial function by environmental factors has been linked to a higher risk of autism spectrum disorders and neurodegenerative disorders. Impacted lipid classes included ceramides, sphingomyelins, and triacylglycerides. Robust ceramide upregulation in the OPFR females could suggest a heightened risk of brain metabolic disease. Conclusions: This study reveals multiple mechanisms by which the components of a common FR mixture are developmentally neurotoxic and that the OPFRs may be the compounds of greatest concern.

15 October 2020 in The Analyst
Verified
Journal Article
Closed access
PDF file
MOMelanie Odenkirk
Melanie Odenkirk
PZPhyo Phyo K. Zin
Phyo Phyo K. Zin
JAJeremy R. Ash
Jeremy R. Ash
David ReifDavid Reif
David Reif
DFDenis Fourches
Denis Fourches
Erin BakerErin Baker
Erin Baker
SCOPE is a toolbox for expanding upon lipid data interpretation capabilities. Herein we utilize SCOPE to explore how lipid structure, biological connections and metadata linkages contribute to the results observed from lipidomic experiments.

21 July 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
YZYun Zhu
Yun Zhu
MOMelanie Odenkirk
Melanie Odenkirk
PQPei Qiao
Pei Qiao
TZTianqi Zhang
Tianqi Zhang
SSSamantha Schrecke
Samantha Schrecke
ALArthur Laganowsky
Arthur Laganowsky
While it is known that lipids play an essential role in regulating membrane protein structure and function, it remains challenging to identify specific protein–lipid interactions.

30 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MOMelanie Odenkirk
Melanie Odenkirk
KSKelly G. Stratton
Kelly G. Stratton
Lisa BramerLisa Bramer
Lisa Bramer
BWBobbie-Jo Webb-Robertson
Bobbie-Jo Webb-Robertson
KBKent J. Bloodsworth
Kent J. Bloodsworth
Erin BakerErin Baker
Erin Baker
While a molecular assessment of the perturbations and injury arising from diseases is essential in their diagnosis and treatment, understanding changes due to preventative strategies is also imperative. Currently, complex diseases such as cardiovascular disease (CVD), the leading cause of death worldwide, suffer from a limited understanding of how the molecular mechanisms taking place following preventive measures (e.g., exercise) differ from changes occurring due to the injuries caused from the disease (e.g., myocardial infarction (MI)). Therefore, this manuscript assesses lipidomic changes before and one hour after exercise treadmill testing (ETT) and before and one hour after a planned myocardial infarction (PMI) in two separate patient cohorts. Strikingly, unique lipidomic perturbations were observed for these events, as could be expected from their vastly different stresses on the body. The lipidomic results were then combined with previously published metabolomic characterizations of the same patients. This integration provides complementary insights into the exercise and PMI events, thereby giving a more holistic understanding of the molecular changes associated with each.

21 July 2026 in Circulation
Verified
Journal Article
Open access
SLShijie Liu
Shijie Liu
SGSeth Gammon
Seth Gammon
LTLin Tan
Lin Tan
YGYaqi Gao
Yaqi Gao
KKKyoungmin Kim
Kyoungmin Kim
AKAnja Karlstaedt
Anja Karlstaedt
BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic interventions. For example, sustained glucose oxidation during cardiac stress is associated with increased activity and abundance of ACL (ATP-dependent citrate lyase, Acly ), which produces acetyl–coenzyme A (CoA) from citrate and CoA and supports de novo lipid synthesis. However, our understanding of how ACL supports cardiac metabolic adaptation and its potential to modulate disease pathophysiology has not yet been investigated. METHODS: We used human heart tissue samples from healthy donors and patients with nonischemic cardiomyopathy. Next, we used CRISPR (clustered, regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated 9) gene editing to inactivate Acly in cardiomyocytes of Myh6-Cas9 mice. In vivo positron emission tomography and ex vivo stable isotope tracer labeling were used to quantify metabolic flux changes in response to Acly knockdown. We conducted a multi-omics analysis using RNA sequencing and mass spectrometry–based metabolomics and proteomics. Experimental data were integrated into computational modeling using the metabolic network CardioNet to identify significantly dysregulated metabolic processes at a systems level. RESULTS: We observed reduced ACL abundance and activity in human heart tissue samples from patients with nonischemic cardiomyopathy, which correlated with decreased abundance of Krebs cycle intermediates. Using CRISPR/Cas9 gene editing, we found that cardiac-specific loss of ACL reduces acetyl-CoA synthesis, leading to altered cardiac metabolism characterized by increased glucose uptake and oxidation, impaired energy flux, and elevated AMP to ATP ratios, which collectively promote left ventricular dysfunction. Transcriptomic and mass spectrometry–based metabolomics, as well as proteomic data, reveal compensatory cardiac lipid remodeling and reduced histone 3 acetylation. This metabolic stress promotes activation of AMPK (AMP kinase) and PKA (protein kinase A), which in turn mediates YAP (Yes-associated protein) inhibition through phosphorylation. Stable isotope tracer studies combined with CardioNet simulations demonstrated that increased IDH1 (isocitrate dehydrogenase 1) activity prevents allosteric inhibition of glycolysis from cytosolic citrate accumulation. AAV9-mediated cardiac Idh1 deletion improved cardiac function and energy provision, reducing YAP phosphorylation and restoring downstream YAP signaling. CONCLUSIONS: Our findings suggest that ACL plays a pivotal role in cardiac metabolism through regulating lipid synthesis and cardiac function. Exploiting compensatory pathways of citrate metabolism may improve cardiac function during heart failure.